Drug Repositioning: Current Advances and Future Perspectives

Drug repositioning is the process of identifying new indications for existing drugs. At present, the conventional de novo drug discovery process requires an average of about 14 years and US$2.5 billion to approve and launch a drug. Drug repositioning can reduce the time and cost of this process beca...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Yuhei Nishimura, Hideaki Hara
Format:	Online
Sprache:	Englisch
Veröffentlicht:	Frontiers Media SA 2021
Schlagworte:	RM1-950 Q1-390 database Integrative strategies molecular docking polypharmacology multi-omics computational analysis Drug Repositioning data sharing Patenting thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
Online-Zugang:	32072
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!